SENP3

Sentrin-specific protease 3 · Q9H4L4 · SENP3 on Sugi Atlas →

7,354 patent compounds predicted against SENP3, 4,127 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL1712890 SCHEMBL1712890 0.58 7/20
SCHEMBL4161888 SCHEMBL4161888 0.56 7/20
SCHEMBL2622737 SCHEMBL2622737 0.54 7/20
SCHEMBL3958375 SCHEMBL3958375 1.00 6/20
SCHEMBL4693271 SCHEMBL4693271 0.68 6/20
SCHEMBL2589316 SCHEMBL2589316 0.60 6/20
SCHEMBL2589319 SCHEMBL2589319 0.60 6/20
SCHEMBL2589308 SCHEMBL2589308 0.60 6/20
SCHEMBL2541489 SCHEMBL2541489 0.57 6/20
SCHEMBL2541491 SCHEMBL2541491 0.57 6/20
SCHEMBL110923 SCHEMBL110923 0.54 6/20
SCHEMBL110924 SCHEMBL110924 0.54 6/20
SCHEMBL1436156 SCHEMBL1436156 0.54 6/20
SCHEMBL4254801 SCHEMBL4254801 0.54 6/20
SCHEMBL4254803 SCHEMBL4254803 0.54 6/20
SCHEMBL1436155 SCHEMBL1436155 0.53 6/20
SCHEMBL4869190 SCHEMBL4869190 0.53 6/20
SCHEMBL414245 SCHEMBL414245 0.52 6/20
SCHEMBL2602447 SCHEMBL2602447 0.48 6/20
SCHEMBL2592201 SCHEMBL2592201 1.00 5/20

Clinical trials — most relevant to SENP3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit PHASE2/PHASE3WITHDRAWN
3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS) PHASE2COMPLETED
Influence of Morphine or Ketamine or Saline Applied During In-hospital Cardiopulmonary Resuscitation on Early Survival PHASE1UNKNOWN
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma nanUNKNOWN
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure nanCOMPLETED
Effect of Dietary Nitrate on Immobilization-induced Changes in Skeletal Muscle in Young Healthy Men nanRECRUITING
Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides of Preterm Newborns: a Pilot Study nanCOMPLETED
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) nanCOMPLETED
Role of Serum ADAM 17 (A Disintegrin And Metalloprotease 17) and Caspase 3 in Patients With Chronic Kidney Disease nanNOT_YET_RECRUITING
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure nanRECRUITING
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 nanCOMPLETED
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Identification of Molecular Marker of Coagulase-negative Staphylococci for the Diagnosis of Prosthetic Joint Infections nanUNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Hydroxychloroquin (HCQ) in chILD of Genetic Defect nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Genetic Determinants of Sudden Cardiac Death nanCOMPLETED
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth nanCOMPLETED
Long Term Prediction of MASH-related HCC Risk by Proteomics nanNOT_YET_RECRUITING
Expression and Clinical Significance of IGHD in Pancreatic Cancer nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SENP3 binder may also engage these)

ProteinNameSimilarity
Q9EP97 0.998 Q9EP97 →
Q8BWQ5 0.991 Q8BWQ5 →
Q5XIX0 0.990 Q5XIX0 →
Q9UPV7 0.989 Q9UPV7 →
Q60700 0.989 Q60700 →
Q80UW3 0.988 Q80UW3 →
Q5BIR3 0.988 Q5BIR3 →
Q8N5Z5 0.988 Q8N5Z5 →
Q3V1D5 0.988 Q3V1D5 →
Q90932 0.987 Q90932 →
O76081 0.987 O76081 →
Q63553 0.987 Q63553 →
P0C6A0 0.987 P0C6A0 →
Q6ZMS7 0.987 Q6ZMS7 →
Q76I79 0.987 Q76I79 →
Q3UJD6 0.987 Q3UJD6 →
Q9Z148 0.986 Q9Z148 →
Q63449 0.986 Q63449 →
Q9BTV7 0.986 Q9BTV7 →
P11299 0.986 P11299 →
Q8N4L4 0.986 Q8N4L4 →
Q9Z0E3 0.986 Q9Z0E3 →
Q8NCU1 0.986 Q8NCU1 →
Q9D1Z2 0.986 Q9D1Z2 →
SENP2 Sentrin-specific protease 2 0.986 landscape →
O43310 0.986 O43310 →
TET3 Methylcytosine dioxygenase TET3 0.986 landscape →
Q8BV79 0.986 Q8BV79 →
USP19 Ubiquitin carboxyl-terminal hydrolase 19 0.986 landscape →
Q66650 0.986 Q66650 →